주 메뉴 바로가기 본문 바로가기 하단 바로가기

A global leading company specialised in biosimilars' distribution

A biosimilar is a biologic product developed and proven to be biologically identical to a previously approved biologic known as the reference product using the same active substances. Known for its high quality and affordability, the biosimilar has become an innovative medicine for patients with different diseases across the world including Europe and the United States.

The first mAb biosimilar
in the world
Over the past few years, Celltrion Healthcare has been offering biosimilars for the treatment of autoimmune diseases in the global market and accumulating its marketing and distribution knowhow. Biosimilars have enabled patient from all over the world to benefit from effective treatments for chronic conditions, whilst reducing the financial burden associated with long term treatments.
Introducing new treatment options
by changing the delivery type
New, alternative modes of delivery offer healthcare specialists the ability to help improve the patient experience of managing a long term condition that requires invasive therapy. Celltrion Healthcare will play a crucial role in making this happen based on the prescription data accumulated over many years and the company's success in the global distribution of its products.

Cookie technology helps us bring you the best possible experience when you visit this website. If you continue without changing your settings, you are agreeing to the cookies on this website. To learn more about our policy on cookies, please review our privacy policy via the link at the bottom of the page.